Aimmune Therapeutics Inc - logo

Aimmune Therapeutics Inc - Company & Market Research Reports

Global Allergy Immunotherapy Market Analysis & Trends - Product Type , Application - Forecast to 2025 - Product Thumbnail Image

Global Allergy Immunotherapy Market Analysis & Trends - Product Type , Application - Forecast to 2025

  • Report
  • 170 Pages
From
Peanut Allergy Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments - Product Thumbnail Image

Peanut Allergy Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments

  • Report
  • 88 Pages
From
Allergies Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Allergies Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • 567 Pages
From
Global Peanut Allergy Market 2019-2023 - Product Thumbnail Image

Global Peanut Allergy Market 2019-2023

  • Report
  • 110 Pages
From
Peanut Allergy - Competitive Landscape, Market Insights, Epidemiology and Market Forecast 2025 - Product Thumbnail Image

Peanut Allergy - Competitive Landscape, Market Insights, Epidemiology and Market Forecast 2025

  • Drug Pipelines
  • 163 Pages
From
Peanut Allergy - Pipeline Review, H2 2018 - Product Thumbnail Image

Peanut Allergy - Pipeline Review, H2 2018

  • Drug Pipelines
  • 117 Pages
From
Peanut Allergy - Pipeline Review, H1 2018 - Product Thumbnail Image

Peanut Allergy - Pipeline Review, H1 2018

  • Drug Pipelines
  • 107 Pages
From
Peanut Allergy: Opportunity Analysis and Forecasts to 2027 - Product Thumbnail Image

Peanut Allergy: Opportunity Analysis and Forecasts to 2027

  • Report
  • 124 Pages
From
Peanut Allergy - Pipeline Insight, 2018 - Product Thumbnail Image

Peanut Allergy - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Breakthrough Therapies: Market Dynamics and Investment Opportunities - Product Thumbnail Image

Breakthrough Therapies: Market Dynamics and Investment Opportunities

  • Report
  • 250 Pages
From
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs - Product Thumbnail Image

Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs

  • Report
  • 181 Pages
From
Type I Hypersensitivity Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Type I Hypersensitivity Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • 565 Pages
From
Peanut Allergy Global Clinical Trials Review, H1, 2018 - Product Thumbnail Image

Peanut Allergy Global Clinical Trials Review, H1, 2018

  • Clinical Trials
  • 71 Pages
From
The Biopharmaceutical Industry in 2018: Key Events and Trends to Watch for by Therapy Area - Product Thumbnail Image

The Biopharmaceutical Industry in 2018: Key Events and Trends to Watch for by Therapy Area

  • Report
  • 55 Pages
From
Hypersensitivity Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Hypersensitivity Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 536 Pages
From
Food Allergy Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Food Allergy Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 118 Pages
From
Q4 2016 Earnings Call - Aimmune Therapeutics, Inc., - Earnings Transcript - Product Thumbnail Image

Q4 2016 Earnings Call - Aimmune Therapeutics, Inc., - Earnings Transcript

  • Earnings Transcript
Aimmune Therapeutics Inc (AIMT) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Aimmune Therapeutics Inc (AIMT) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • 25 Pages
From
Aimmune Therapeutics Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report - Product Thumbnail Image

Aimmune Therapeutics Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

  • Financial Report
  • 35 Pages
From
AR101 Phase III Trail Results Call - Aimmune Therapeutics, Inc. - Earnings Transcript - Product Thumbnail Image

AR101 Phase III Trail Results Call - Aimmune Therapeutics, Inc. - Earnings Transcript

  • Earnings Transcript
Loading Indicator
adroll